市场情绪：20260107 市场情绪较为高涨，收盘时有 96 只股票涨停，有 7 只股票跌停。昨日涨停股票今日收盘收益为 1.51%，昨日跌停股票今日收盘 收益为-3.37%。今日封板率 64%，较前日下降 19%，连板率 24%，较前日 下降 18%。 市场资金流向：截至 20260106 两融余额为 25799 亿元，其中融资余额 25623 亿元，融券余额 176 亿元。两融余额占流通市值比重为 2.5%，两融 交易占市场成交额比重为 11.6%。 折溢价：20260106 当日 ETF 溢价较多的是中证 500 价值 ETF，ETF 折价 较多的是 G60 创新 ETF。近半年以来大宗交易日均成交金额达到 22 亿元， 20260106 当日大宗交易成交金额为 26 亿元，近半年以来平均折价率 6.69%，当日折价率为 9.26%。近一年以来上证 50、沪深 300、中证 500、 中证 1000 股指期货主力合约的年化贴水率中位数分别为 0.85%、3.79%、 11.15%、13.61%，当日上证 50 股指期货主力合约年化贴水率为 0.23%， 处于近一年来 60%分位点，当日沪深 300 股指 ...

Market Overview - On the first trading day of 2026, the Shanghai Composite Index rose by 1.38% to 4023.42 points, while the Shenzhen Component Index increased by 2.24% and the ChiNext Index by 2.85%. The total trading volume in the Shanghai and Shenzhen markets reached 2.55 trillion yuan. The leading sectors included media, pharmaceuticals, and electronics, while oil and petrochemicals, banking, and transportation lagged behind [2][7] - The Hong Kong Hang Seng Index saw a slight increase of 0.03%, closing at 26347.24 points, while the U.S. major indices all closed higher, with the Dow Jones Industrial Average rising by 1.23% to a record high of 48977.18 points [2][7] Important News - Premier Li Qiang emphasized the need to enhance innovation and development advantages during his research in Guangdong, advocating for the improvement of industrial ecosystems and the exploration of effective business models for new technologies such as robots and drones [3][8] - A joint announcement from nine departments, including the Ministry of Commerce, implemented actions to promote green consumption, focusing on enhancing the supply of green products and encouraging the purchase of electric vehicles and certified green appliances [3][8] Industry Insights Media Industry - The New Year's Day box office exceeded 740 million yuan, marking a significant increase of 61.01% compared to the previous year. The extended holiday period allowed for a diverse range of films to cater to audience preferences, with major sequels leading the box office [9][10] - The total number of screenings during the New Year's holiday reached 1.417 million, with a notable increase in audience attendance, particularly on January 1, which saw a 14.20% year-on-year increase [10][12] - Major IP sequels like "Zootopia 2" and "Avatar 3" demonstrated strong box office resilience, contributing significantly to the overall market performance [12] Gaming Industry - In December 2025, a total of 147 game titles received approval, with 144 domestic and 3 imported games. The total number of game approvals for the year reached 1771, a 25.07% increase from 2024 [13][14] - The game "Seven Realms Dream" is highlighted for its unique "national style" theme and innovative gameplay mechanics, indicating a competitive landscape in the MMO sector for 2026 [14][15] Tourism Industry - The 2026 New Year's holiday saw 142 million domestic trips and total spending of 847.89 billion yuan, benefiting from the extended holiday period compared to the previous year [16][17] - The tourism market experienced a boost due to various factors, including the popularity of winter sports, the appeal of Hainan's free trade zone, and increased interest in outbound travel [18][19] - The outlook for 2026 remains positive, with expectations for further growth in the tourism sector driven by favorable policies and consumer confidence [19]

写在文章前的声明：在本文之前的说明：本文中所列的投资信息，只是一个对基金资产净值进行排行的客观描述，并无主观倾向性，也不是投资建议，纯属 娱乐性质。 一顿操作猛如虎，基金净值已更新，谁是基金中的王者，谁又垫底，请看数据： 5日开放式基金净值增长排名后10的基金分别是：华宝海外新能源汽车股票发起式(QDII)A、华宝海外新能源汽车股票发起式(QDII)C、摩根中国世纪混合 (QDII)人民币、天弘全球高端制造混合(QDII)C、天弘全球高端制造混合(QDII)A、创金合信全球医药生物股票发起(QDII)C、创金合信全球医药生物股票发 起(QDII)A、景顺长城全球半导体芯片股票A(QDII-LOF)(人民币)、景顺长城全球半导体芯片股票C(QDII-LOF)(人民币)、嘉实全球产业升级股票发起式 (QDII)C。 | 基金简称 PK | | | 最新净体系 引导 2018 000 | | | --- | --- | --- | --- | --- | | 1 | 华银健康生 ... 置 | 1.2860 | 11.83% | | | | 001056 | 2026-1-5 | | | | 2 | 中银健康生 . ...

证券研究报告 | 2026年01月05日 金融工程日报 沪指 12 连阳重返 4000 点，刷新近 33 年以来连阳记录 核心观点 金融工程日报 市场表现：20260105 市场全线上涨，规模指数中中证 500 指数表现较好， 板块指数中科创 50 指数表现较好，风格指数中中证 500 成长指数表现较好。 传媒、医药、电子、非银、计算机行业表现较好，综合金融、石油石化、消 费者服务、交通运输、银行行业表现较差。脑机接口、血氧仪、医疗器械精 选、存储器、保险精选等概念表现较好，海南自贸港、家纺、钢铁股精选、 海航系等概念表现较差。 市场情绪：20260105 市场情绪较为高涨，收盘时有 127 只股票涨停，有 13 只股票跌停。昨日涨停股票今日收盘收益为 2.58%，昨日跌停股票今日收盘 收益为-2.51%。今日封板率 76%，较前日提升 5%，连板率 30%，较前日 提升 11%。 市场资金流向：截至 20251231 两融余额为 25407 亿元，其中融资余额 25242 亿元，融券余额 165 亿元。两融余额占流通市值比重为 2.6%，两融 交易占市场成交额比重为 10.6%。 折溢价：20251231 ...

今日（1月5日），A股喜迎开门红，三大指数集体上涨。市场全天成交额2.57万亿元，较前一交易日放 量超5000亿元，收盘上涨个股超4100只。 盘面上，脑机接口领涨，高压氧舱、血氧仪、2025年报预增等概念跟涨。海南自贸区、免税店、自由贸 易港等概念跌幅居前。 11股今日获机构买入评级 据证券时报 数据宝统计，今日机构研报共发布13条买入型评级记录，共涉及11只个股。天赐材料、贵 州茅台关注度较高，均有2次机构买入型评级记录。 获机构买入型评级个股中，共有5条评级记录中对相关个股给出了预测目标价。以公布的预测目标价与 最新收盘价进行对比显示，共有5股上涨空间超10%，贵州茅台上涨空间最高，1月5日华创证券预计公 司目标价为2600元，上涨空间达82.33%；上涨空间较高的个股还有旗滨集团、石基信息等，上涨空间 分别为73.03%、30.30%。 市场表现方面，机构买入型评级个股今日平均上涨2.26%，表现强于沪指。股价上涨的有10只，涨幅居 前的有旗滨集团、石基信息、天赐材料等，今日涨幅分别为5.06%、4.52%、3.69%。 | 代码 | 盲标 | 机构名称 | 取新评级 | 上次评级 | 机构预测目标价 ...

| 000959 | 首钢股 | -0.82 | 0.64 | 307.47 | 1.31 | | --- | --- | --- | --- | --- | --- | | | 份 | | | | | | 600983 | 惠而浦 | 2.41 | 0.42 | 127.33 | 4.08 | | 002010 | 传化智 | 4.65 | 3.05 | 74.39 | 0.15 | | | 联 | | | | | | 688796 | 百奥赛 | 4.66 | 17.73 | -244.72 | -0.70 | | | 图 | | | | | | 300620 | 光库科 | 3.15 | 5.54 | -5119.47 | -2.48 | | | 技 | | | | | 资金面上看，今日2025年报预增概念板块获主力资金净流入16.28亿元，其中，10股获主力资金净流 入，5股主力资金净流入超3000万元，净流入资金居首的是紫金矿业，今日主力资金净流入9.02亿元， 净流入资金居前的还有盐湖股份、C强一、大洋生物等，主力资金分别净流入5.08亿元、1.27亿元、 8189.03万元。 资金流入比率方面， ...

芬太尼概念资金流入榜 | 代码 | 简称 | 今日涨跌幅 | 今日换手率 | 主力资金流量（万 | 主力资金净流入比率 | | --- | --- | --- | --- | --- | --- | | | | （%） | （%） | 元） | （%） | | 600079 | ST人福 | 2.26 | 1.67 | 6989.38 | 14.70 | | 600511 | 国药股 份 | 1.04 | 1.10 | 1047.55 | 5.96 | | 600420 | 国药现 代 | 1.39 | 0.72 | 756.81 | 7.69 | | 600285 | 羚锐制 药 | 4.88 | 2.83 | 479.39 | 1.39 | | 300482 | 万孚生 物 | 2.13 | 1.25 | 441.22 | 4.09 | | 688298 | 东方生 物 | 5.12 | 1.59 | 238.15 | 3.05 | | 002262 | 恩华药 业 | 1.12 | 1.29 | -105.69 | -0.38 | 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | ...

迈瑞医疗所属申万行业为：医药生物-医疗器械-医疗设备。所属概念板块包括：血氧仪、宠物经济、医 疗器械、智慧医疗、体外诊断等。 截至9月30日，迈瑞医疗股东户数10.88万，较上期增加18.86%；人均流通股11139股，较上期减少 15.87%。2025年1月-9月，迈瑞医疗实现营业收入258.34亿元，同比减少12.38%；归母净利润75.70亿 元，同比减少28.83%。 分红方面，迈瑞医疗A股上市后累计派现353.36亿元。近三年，累计派现250.25亿元。 机构持仓方面，截止2025年9月30日，迈瑞医疗十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1.17亿股，相比上期减少1473.63万股。易方达创业板ETF（159915）位居第五大流通股 东，持股1169.35万股，相比上期减少195.91万股。华泰柏瑞沪深300ETF（510300）位居第六大流通股 东，持股1033.58万股，相比上期减少48.07万股。华宝中证医疗ETF（512170）位居第七大流通股东， 持股947.20万股，相比上期减少154.04万股。易方达沪深300医药ETF（512010）位居第九大流通股东， 持 ...

Company Overview - Mindray Medical is a leading company in the medical device industry, focusing on the research, manufacturing, marketing, and service of medical instruments [1][2] - The company was established on January 25, 1999, and went public on October 16, 2018 [1] Financial Performance - For the period from January to September 2025, Mindray Medical reported a revenue of 25.834 billion yuan, a year-on-year decrease of 12.38% [2] - The net profit attributable to the parent company for the same period was 7.570 billion yuan, down 28.83% year-on-year [2] - Since its A-share listing, the company has distributed a total of 35.336 billion yuan in dividends, with 25.025 billion yuan distributed over the past three years [3] Stock Performance - As of November 27, Mindray Medical's stock price increased by 2.02% to 197.31 yuan per share, with a total market capitalization of 239.227 billion yuan [1] - The stock has experienced a decline of 21.19% year-to-date, with a 0.77% drop over the last five trading days and an 8.37% decrease over the last 20 days [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 18.86% to 108,800, while the average number of circulating shares per person decreased by 15.87% to 11,139 shares [2] - The top ten circulating shareholders include significant institutional investors, with notable reductions in holdings among several ETFs [3]

Core Viewpoint - Lepu Medical's stock price has shown a year-to-date increase of 43.28%, but has recently experienced declines over various trading periods, indicating potential volatility in the market [1][2]. Group 1: Stock Performance - On November 24, Lepu Medical's stock rose by 2.06%, reaching a price of 15.83 CNY per share, with a trading volume of 1.53 billion CNY and a turnover rate of 0.62%, resulting in a total market capitalization of 29.181 billion CNY [1]. - The stock has seen a net outflow of 11.1739 million CNY from major funds, with significant selling pressure observed [1]. - Year-to-date, the stock has increased by 43.28%, but has declined by 3.00% over the last five trading days, 11.02% over the last 20 days, and 12.06% over the last 60 days [1]. Group 2: Company Overview - Lepu Medical, established on June 11, 1999, and listed on October 30, 2009, is based in Changping District, Beijing, and operates in the medical device sector, including cardiac treatment products, in vitro diagnostic reagents, and medical services [2]. - The company's revenue composition includes 52.72% from medical devices, 33.16% from pharmaceuticals, and 14.11% from medical services and health management [2]. - Lepu Medical is categorized under the pharmaceutical and biological industry, specifically in medical devices and consumables, and is involved in various innovative sectors such as brain-machine interfaces and smart healthcare [2]. Group 3: Financial Performance - For the period from January to September 2025, Lepu Medical reported a revenue of 4.939 billion CNY, reflecting a year-on-year growth of 3.20%, while the net profit attributable to shareholders was 982 million CNY, marking a 22.35% increase [2]. - The company has distributed a total of 4.957 billion CNY in dividends since its A-share listing, with 2.058 billion CNY distributed over the past three years [3]. - As of September 30, 2025, Lepu Medical had 82,900 shareholders, a decrease of 17.13% from the previous period, with an average of 19,490 circulating shares per shareholder, an increase of 20.67% [2].